Special Issue "Natural Products for Potential Use of Neuroprotective and Neurorestorative Effects"
Deadline for manuscript submissions: 25 February 2024 | Viewed by 656
Interests: neurodegenerative disease; natural compounds; nutraceuticals; nutritional interventions; cognitive impairment
Interests: neuroinflammation; neurodegeneration; nutraceuticals; cognitive impairment; natural compounds
Special Issues, Collections and Topics in MDPI journals
Neurodegenerative diseases result from a variety of pathological conditions characterized by significant cellular damage, abnormal protein presence and altered connections of the nervous system that can impair the patient's life quality. It is estimated that neurodegenerative diseases affect millions of individuals worldwide and the likelihood of developing neurodegenerative disease increases dramatically with age. The presence of abnormal proteins and increased oxidative stress contribute to accelerating neuroinflammatory and neurodegenerative processes. To date, considerable progress has been made in identifying the molecular mechanisms and pathways underlying neurodegenerative diseases; however, identifying safe and effective drug therapies for treating these disorders is very arduous. Pharmacological therapies in use for the treatment of neurodegenerative disease are still ineffective in modifying pathological changes and neurological disorders, and they provide only symptomatic relief; therefore, it is essential to seek new therapeutic strategies to treat these diseases. Natural compounds have aroused considerable interest in this field, also proving to be a possible alternative to the synthetic drugs used. Natural compounds may exert positive effects on aging-related changes in the brain and are capable of modulating neurological processes, given their ability to interact with neuronal–glial signaling pathways that are implicated in neuronal survival and function. In this Special Issue, we aim to bring together research from experts in the field highlighting the neuroprotective capabilities of natural compounds to identify future directions that will lead to discoveries and alternative therapies for neurological disorders.
Dr. Lorenza Guarnieri
Dr. Francesca Bosco
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- neurodegenerative disease
- nutritional interventions
- brain damage
- neurological diseases
- natural compounds